Archive for January 2022

Considerations for Ensuring Optimal Digital Adherence Monitoring

Ensuring Optimal Medication Adherence Monitoring

It’s no secret, recruiting clinical trial participants is difficult, time-consuming, and considerably expensive, all while dropout rates are notoriously high across therapeutic areas. Whatever the motive for dropout, the impact is huge. Trials can become underpowered and may not have enough data to effectively demonstrate either statistically significant clinical benefit or the safety of the…

Read More

Addressing Medication Adherence in Decentralized Clinical Trials

Adherence in Decentralized Clinical Trials

Adherence monitoring can minimize variability and maximize engagement in DCTs Decentralized clinical trials (DCT) are growing in popularity, thanks to their ability to tear down many of the long-standing barriers to robust medical research. And while this new model has some challenges of its own, focusing on adherence can help tackle them head-on. COVID-19 accelerated…

Read More

Improving Clinical Trial ROI with Medication Adherence Management

Study power is the Holy Grail of clinical trials, setting drug developers on the quickest path to market – but non-adherence causes costly detours. When participants do not take their medication as specified in the study protocol, it can result in underestimated drug efficacy, delay the approval of investigational products, and contribute to rising costs.…

Read More